Cellular senescence in cancer: molecular mechanisms and therapeutic targets
MedComm · 2024-05 · 5 (5)
DOI: 10.1002/mco2.542 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 24.04.2024. Verfasst von Ping Jin und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Conservation and Utilization of Bio-Resources in Yunnan, School of Life Sciences Yunnan University Kunming Yunnan China. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 369 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Department of Sichuan Province.
Abstract (Originalsprache)
Aging exhibits several hallmarks in common with cancer, such as cellular senescence, dysbiosis, inflammation, genomic instability, and epigenetic changes. In recent decades, research into the role of cellular senescence on tumor progression has received widespread attention. While how senescence limits the course of cancer is well established, senescence has also been found to promote certain malignant phenotypes. The tumor‐promoting effect of senescence is mainly elicited by a senescence‐associated secretory phenotype, which facilitates the interaction of senescent tumor cells with their surroundings. Targeting senescent cells therefore offers a promising technique for cancer therapy. Drugs that pharmacologically restore the normal function of senescent cells or eliminate them would assist in reestablishing homeostasis of cell signaling. Here, we describe cell senescence, its occurrence, phenotype, and impact on tumor biology. A “one‐two‐punch” therapeutic strategy in which cancer cell senescence is first induced, followed by the use of senotherapeutics for eliminating the senescent cells is introduced. The advances in the application of senotherapeutics for targeting senescent cells to assist cancer treatment are outlined, with an emphasis on drug categories, and the strategies for their screening, design, and efficient targeting. This work will foster a thorough comprehension and encourage additional research within this field.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory for Conservation and Utilization of Bio-Resources in Yunnan, School of Life Sciences Yunnan University Kunming Yunnan China.
- Department of Oncology School of Medicine Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital University of Electronic Science and Technology of China Chengdu Sichuan China.
- Department of Anorectal Surgery Hospital of Chengdu University of Traditional Chinese Medicine and Chengdu University of Traditional Chinese Medicine Chengdu China.
Förderung
- Science and Technology Department of Sichuan Province
Zitieren
APA
Jin, P., Duan, X., Li, L., Zhou, P., Zou, C. G., & Xie, K. (2024). Cellular senescence in cancer: molecular mechanisms and therapeutic targets. MedComm, 5(5). https://doi.org/10.1002/mco2.542
Vancouver
Jin P, Duan X, Li L, Zhou P, Zou CG, Xie K. Cellular senescence in cancer: molecular mechanisms and therapeutic targets. MedComm. 2024;5(5). doi:10.1002/mco2.542
BibTeX
@article{Jin2024,
author = {Jin, Ping and Duan, Xirui and Li, Lei and Zhou, Ping and Zou, Cheng-Gang and Xie, Ke},
title = {Cellular senescence in cancer: molecular mechanisms and therapeutic targets},
journal = {MedComm},
year = {2024},
volume = {5},
number = {5},
doi = {10.1002/mco2.542}
}
EUVIMED